Welcome to the BioPharma Companies and Products in the Pipeline!

Biopharmaceuticals are generally complex macromolecules derived from recombinant DNA technology, cell fusion, or processes involving genetic manipulation. They include recombinant proteins, genetically engineered vaccines; therapeutic monoclonal antibodies; and nucleic acid based therapeutics, including gene therapy vectors.

Canada’s biopharmaceutical product pipeline has an abundance of new product innovations at various stages of development. We invite you to utilize the search engine to explore the companies and products that are being developed to discover the creativity and excellence within the Canadian biopharmaceutical industry.